Skip to main content
Voices from the Doximity Network
Use App
Browse
Submit
Toggle Menu
All Articles
Conferences
From the Editors
Medical Humanities
Medical Insights
Browse
Submit
ASCO GU
ASCO GU Conference Content
PD1/L1 Inhibitor Therapy for Muscle-Invasive Bladder Cancer: Adjuvant or Neoadjuvant + Adjuvant?
Guru P Sonpavde, MD
Feb 21, 2025